We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

172 hedge funds and large institutions have $2.33B invested in Aerie Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 70 increasing their positions, 53 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 53

2% more capital invested

Capital invested by funds: $2.29B → $2.33B (+$41.7M)

4% less funds holding

Funds holding: 179 → 172 (-7)

25% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 24

27% less call options, than puts

Call options by funds: $15.7M | Put options by funds: $21.5M

36% less funds holding in top 10

Funds holding in top 10: 11 → 7 (-4)

Holders
172
Holders Change
-7
Holders Change %
-3.91%
% of All Funds
3.94%
Holding in Top 10
7
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-36.36%
% of All Funds
0.16%
New
18
Increased
70
Reduced
53
Closed
24
Calls
$15.7M
Puts
$21.5M
Net Calls
-$5.87M
Net Calls Change
-$24.7M

Top Buyers

Rank Fund Capital Flow
1
HM
HealthCor Management
New York
+$67.1M
2
Invesco
Invesco
Georgia
+$40.6M
3
O
OrbiMed
New York
+$31M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$30M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$25.7M

Top Sellers

Rank Fund Capital Flow
1
SAM
Senzar Asset Management
New York
-$11.6M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$10M
3
IHM
Iguana Healthcare Management
New York
-$5.08M
4
RPAM
Rhenman & Partners Asset Management
Sweden
-$4.86M
5
BBA
Baker Bros. Advisors
New York
-$4.68M
Name Holding Trade Value Shares
Change 		Change in
Stake
TCIM
51
TIAA CREF Investment Management
New York
$4.9M +$55.7K +996 +1%
PPA
52
Parametric Portfolio Associates
Washington
$4.34M -$207K -3,698 -4%
CS
53
Candriam SCA
Luxembourg
$4.29M +$392K +7,000 +10%
Stifel Financial
54
Stifel Financial
Missouri
$4.18M -$463K -8,282 -10%
EIM
55
Essex Investment Management
Massachusetts
$4.18M – – –
NCGI
56
Next Century Growth Investors
Minnesota
$4.01M -$1.04M -18,564 -20%
CWG
57
C WorldWide Group
Denmark
$3.95M -$528K -9,449 -11%
SAM
58
Senzar Asset Management
New York
$3.83M -$11.6M -207,732 -75%
ACM
59
Asymmetry Capital Management
California
$3.78M +$1.64M +29,346 +73%
TAM
60
Tocqueville Asset Management
New York
$3.59M -$4.56M -81,465 -55%
BI
61
Boulegeris Investments
Georgia
$3.57M -$252K -4,500 -6%
Macquarie Group
62
Macquarie Group
Australia
$3.55M +$720K +12,879 +24%
Deutsche Bank
63
Deutsche Bank
Germany
$3.53M -$1.29M -23,113 -26%
TRSOTSOK
64
Teachers Retirement System of the State of Kentucky
Kentucky
$3.43M +$28K +500 +0.8%
Prudential Financial
65
Prudential Financial
New Jersey
$3.14M +$273K +4,890 +9%
PCM
66
Prelude Capital Management
New York
$3.09M +$1.4M +24,974 +78%
Balyasny Asset Management
67
Balyasny Asset Management
Illinois
$3.08M -$1.41M -25,189 -31%
American Century Companies
68
American Century Companies
Missouri
$3.06M +$1.27M +22,751 +68%
Swiss National Bank
69
Swiss National Bank
Switzerland
$2.92M +$72.7K +1,300 +2%
California State Teachers Retirement System (CalSTRS)
70
California State Teachers Retirement System (CalSTRS)
California
$2.81M -$22.9K -409 -0.8%
AA
71
ALPS Advisors
Colorado
$2.74M +$553K +9,883 +24%
HI
72
Handelsinvest Investeringsforvaltning
Denmark
$2.46M – – –
PC
73
PointState Capital
New York
$2.44M +$2.52M +45,076 New
WMSA
74
Weiss Multi-Strategy Advisers
New York
$2.44M -$559K -10,000 -18%
MAP
75
Moody Aldrich Partners
Massachusetts
$2.23M +$515K +9,201 +29%
1 2
3
4 5

AERI Hedge Fund Activity: Q1 2018 in Review

172 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q1 2018, worth a combined $2.33B — up 1.8% from $2.29B a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of AERI and 18 opened new positions — a net loss of 6 holders — while 53 trimmed existing stakes and 70 added.

The largest buyer was HealthCor Management, opening a new position worth an estimated $67.1M. The largest seller was Senzar Asset Management, cutting an estimated $11.6M.

  • 172 institutional investors held Aerie Pharmaceuticals (AERI) as of Q1 2018, down from 179 in Q4 2017.
  • Funds reported $2.33B of Aerie Pharmaceuticals stock for Q1 2018, up 1.8% quarter-over-quarter.
  • 18 funds opened new Aerie Pharmaceuticals positions in Q1 2018 and 24 closed out, a net change of -6 holders.
  • The largest Aerie Pharmaceuticals buyer in Q1 2018 was HealthCor Management, an estimated $67.1M added.
  • The largest Aerie Pharmaceuticals seller in Q1 2018 was Senzar Asset Management, an estimated $11.6M sold.

Based on aggregated 13F filings for Q1 2018.